1. Introduction {#sec1}
===============

Anterior cruciate ligament (ACL) reconstruction (ACLR) has become a popular and effective surgery for the management of ACL injury \[[@B1]--[@B4]\]. However, the reinjury rate is still high, and a number of patients with poor clinical outcomes are observed at long-term follow-up \[[@B5], [@B6]\]. To achieve better knee stability and clinical outcomes, remnant-preserving ACLR, with its potential advantages of promoting faster graft revascularization and maturation, has been studied and compared to standard ACLR.

Many histological and animal studies have confirmed that ACL remnants retain a well-vascularized synovial sheet, numerous fibroblasts and myofibroblasts, and mechanoreceptors \[[@B7]--[@B13]\]. Some authors claim that remnants can accelerate the process of synovial coverage and revascularization and enhance the biomechanical properties of grafts in animals \[[@B8], [@B14]\]. However, many studies \[[@B15]--[@B25]\] have reported inconsistent clinical outcomes when comparing remnant-preserving ACLR to standard ACLR. Some studies \[[@B17], [@B22]\] have reported better arthroscopic evaluations and clinical outcomes for remnant-preserving ACLR. Other studies \[[@B16], [@B24]\] have found that remnant preservation can induce an increased incidence of postoperative extension loss. Several previous reviews have summarized these results. Papalia et al. \[[@B26]\] found significant postoperative improvements in patients undergoing remnant-preserving ACLR. Hu et al. \[[@B27]\] reported that the short-term clinical outcomes of patients with remnant-preserving ACLR are comparable to those of patients with standard ACLR. Two meta-analysis reviews \[[@B28], [@B29]\] reported similar clinical results between remnant-preserving ACLR and standard ACLR. However, previous systematic reviews are limited by their inclusion of a low level of evidence-based research. Based on previous studies, this review included new and high-quality studies with level I or level II evidence to perform a systematic review of the techniques and a meta-analysis of the functional and objective outcomes after remnant-preserving ACLR versus standard ACLR.

In clinical practice, the point of focus is not just the restoration of the biomechanics of the ACL by surgery; the biological healing of the ACL is a more important factor. At present, clinical studies show inconsistent results in graft healing by remnant-preserving ACLR \[[@B16], [@B17], [@B22], [@B24]\]. Therefore, the debate continues as to whether remnant-preserving ACLR promotes better graft healing than standard ACLR.

This is a systematic review and meta-analysis of current evidence that aims at comparing the clinical outcomes of remnant-preserving anterior cruciate ligament reconstruction (ACLR) and standard ACLR. We hypothesized that remnant-preserving ACLR could produce superior clinical outcomes to those of standard ACLR.

2. Methods {#sec2}
==========

2.1. Literature Search {#sec2.1}
----------------------

A systematic search of 4 databases, namely, PubMed, EMBASE, Medline Ovid, and Cochrane Library, was performed by two authors independently on December 10, 2018. The base terms used in each search included "anterior cruciate ligament remnant," "ACL augmentation," "ACL preservation," "ACL stump," "selective ACLR," and "ACL remnant reconstruction." The levels of evidence, namely, I and II (according to the Oxford Centre for Evidence-Based Medicine used by the Journal of Bone & Joint Surgery American Volume and Arthroscopy \[[@B30]\]), were reviewed for study inclusion. Two authors independently selected all articles by reviewing full-text reports according to the inclusion and exclusion criteria. Any disagreements between the two authors at the stage of inclusion were resolved through discussion with the corresponding author.

2.2. Study Selection {#sec2.2}
--------------------

Studies were considered eligible if they met the following criteria: an adequate description of the remnant preservation technique for ACLR; reports of both preoperative conditions and postoperative clinical outcomes after primary remnant-preserving ACLR; level I or II evidence; studies that included subjective and objective outcomes; written in English; use of human subjects; and a study publication or in-press online date between January 1, 2000, and December 10, 2018. The exclusion criteria for this article are as follows: the follow-up period was less than one year; level III or IV evidence; study that does not directly compare the outcome of remnant-preserving ACLR and standard ACLR; and operative interventions were not described in the article. If the same population was included in more than one study, we included the study with the longest duration of follow-up.

2.3. Quality Assessment {#sec2.3}
-----------------------

The modified Coleman methodology score (CMS) \[[@B31]\], which comprises a 10-criterion validated score, was used to assess the methodological quality of each article by 2 authors. Each of the 10 criteria was scored to generate a total score between 0 and 100. A high score indicates a study design that largely avoids the influences of chance, different biases, and confounding factors.

2.4. Data Extraction {#sec2.4}
--------------------

The extracted data were compared and discussed to meet consistency by all authors. Data extracted from each study included in this review were summarized as the (1) preoperative conditions, (2) postoperative clinical outcomes, and (3) postoperative complications of patients after remnant-preserving ACLR or after standard ACLR.

Each study was divided into 2 groups, namely, patients undergoing remnant-preserving ACLR and those undergoing standard ACLR. The postoperative outcomes and complications in the 2 groups of each study were proactively assessed and compared, which provided evidence to evaluate the effects of remnant-preserving ACLR. The items of the preoperative condition included (1) time from injury to surgery, (2) pattern of ACL rupture, (3) amount of ACL remnant, (4) type of ACL graft, and (5) surgical procedure ([Table 1](#tab1){ref-type="table"}). The items of postoperative clinical outcome and complications included (1) time of follow-up, (2) stability and functional outcomes, (3) graft revascularization process, (4) proprioceptive testing, and (5) postoperative complications in all studies ([Table 2](#tab2){ref-type="table"}).

2.5. Statistical Analysis {#sec2.5}
-------------------------

Continuous variable data (e.g., Lysholm scores) were collected as mean ± standard deviation from the mean. The differences were reported as weighted mean differences (WMDs). Dichotomous data (e.g., IKDC grade A or B vs. grade C or D) were reported as odds ratios. Two types of data were presented with 95% confidence intervals (CIs). When feasible, meta-analysis was performed with RevMan5.3 software (the Nordic Cochrane Centre, the Cochrane Collaboration, Copenhagen, Denmark). Random-effects models rather than the fixed-effects models were chosen to combine studies. Because random-effects models properly take into account heterogeneity when a few studies are combined, such as differences in study design. Significance was set at *P* \< 0.05. Heterogeneity was assessed using *I*^2^. The values of *I*^2^ \<25%, 50%, and \>75% were interpreted as small, moderate, and high levels of heterogeneity, respectively. For quantitative syntheses including randomized controlled trials and prospective cohort studies, subgroup meta-analyses were presented for each study type group.

3. Results {#sec3}
==========

3.1. Literature Search {#sec3.1}
----------------------

A total of 237 relevant articles were initially identified according to the search strategy. One hundred fifty-three were excluded after reviewing the title because they were irrelevant to the topic. Sixty-four were excluded after reviewing the abstract. Nine were excluded according to low-level evidence or review articles. Finally, eleven high-level evidence proactive articles were included in this systematic review. [Figure 1](#fig1){ref-type="fig"} illustrates the search strategy for this review. The features of the levels of evidence for each included study are listed in [Table 3](#tab3){ref-type="table"}.

3.2. Quality Assessment {#sec3.2}
-----------------------

All studies \[[@B15]--[@B25]\] that are included in this review are RCTs or prospective cohort studies, which provide strong assurance of study quality. The outcome criteria of the included study were clearly defined and reported good reliability, which included a subjective scoring system, physical examination, and second-look operation in partial patients. Each study had a minimal 1-year follow-up time with *a* \> 80% recruitment rate. The mean modified CMS for all included studies was 85.8 (ranging from 77 to 92). The CMS scores and the detailed CMS of each study are shown in Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}, respectively.

3.3. Data Abstraction {#sec3.3}
---------------------

In total, 466 patients underwent remnant-preserving ACLR by 3 different procedures: standard ACLR plus tibial remnant tensioning (*n* = 283), selective-bundle augmentation (*n* = 49), and standard ACLR plus tibial remnant sparing (*n* = 134). Surgical descriptions are presented in [Table 5](#tab5){ref-type="table"} \[[@B32]--[@B34]\].

The outcomes of patients after remnant-preserving ACLR (*n* = 466) and after standard ACLR (*n* = 536) were directly compared and included knee stability, clinical scoring system, and graft status.

3.4. Clinical Scoring System {#sec3.4}
----------------------------

Lysholm score was reported in nine studies (5 RCT and 4 cohort studies) \[[@B15], [@B16], [@B18], [@B21]--[@B25]\]. The pooled difference in mean postoperative value in RCT was 2.01 (95% CI, 0.53 to 3.50; *P* \< 0.01) with moderate heterogeneity (*I*^2^ = 29%), in favor of the R group (remnant-preserving ACLR group). The pooled difference in the mean score in cohort studies was 0.43 (95% CI, −0.33 to 1.20; *P*=0.26), and no difference was found between the groups ([Figure 2](#fig2){ref-type="fig"}).

International Knee Documentation Committee (IKDC) subject scores were conducted in three RCT studies \[[@B19], [@B23], [@B25]\]. No significant difference was found between the two groups with respect to IKDC subject scores (WMD = 0.07, 95% CI, −1.54, 1.67; *P*=0.94) ([Figure 3](#fig3){ref-type="fig"}).

Three studies were reviewed with respect to IKDC grades \[[@B22], [@B24], [@B25]\]. Superior results were defined as IKDC grade A or B. There was no significant difference between the two groups (OR = 2.05, 95% CI, 0.70, 5.97; *P*=0.19) ([Figure 4](#fig4){ref-type="fig"}).

3.5. Knee Stability {#sec3.5}
-------------------

Anterior laxity was evaluated with a KT-1000/2000 arthrometer or the laxity Rolimeter in eight studies (4 RCT and 4 cohort studies) \[[@B15]--[@B17], [@B19]--[@B22], [@B24], [@B25]\]. A significant difference was found in arthrometer measurements in favor of the R group when evaluating RCT studies only (WMD = −0.42, 95% CI, −0.66, −0.17; *P* \< 0.01) with moderate heterogeneity (*I*^2^ = 36%). Similar result was found in cohort studies (WMD = −0.35, 95% CI, −0.69, 0; *P*=0.05) ([Figure 5](#fig5){ref-type="fig"}). Meta-analysis revealed that postoperative side-to-side difference in anterior laxity was smaller in the remnant-preserving ACLR group than in the standard group.

Lachman test was reported in four studies \[[@B19], [@B23], [@B24]\]. No difference was found in Lachman test between groups (OR = 0.78, 95% CI, 0.35, 1.76; *P*=0.56) ([Figure 6](#fig6){ref-type="fig"}).

Pivot-shift test was reported in three studies \[[@B22]--[@B25]\]. No difference was found between groups respect to pivot-shift test (OR = 0.96, 95% CI, 0.44, 2.10; *P*=0.91) ([Figure 7](#fig7){ref-type="fig"}).

3.6. Status of Graft {#sec3.6}
--------------------

Revascularization of the graft was evaluated by MRI in two studies. One study \[[@B15]\] reported similar maturation scores and tibial tunnel integration scores between groups. Another study \[[@B19]\] indicated a significant reduction in the midsubstance signal in the R group at 2 and 6 months postoperatively. Two studies \[[@B21], [@B23]\] reported better tibial tunnel widening in radiographs in the R group than in the C group.

The graft status was evaluated by second-look arthroscopy in four studies (2 RCT and 2 cohort studies) \[[@B16], [@B17], [@B22], [@B24]\]. Several different methods were reported in previous studies to evaluate graft quality by second-look arthroscopy \[[@B33], [@B35], [@B36]\]. The main point of all those methods focuses on laceration of graft and synovial coverage and evaluates the score accordingly. Therefore, superior results were defined as grade A (grades A, B, and C) proposed by Kondo and Yasuda \[[@B35]\] or good (good, fair, and poor) proposed by Ochi et al. \[[@B33]\]. There was no significant difference in RCT studies between the two groups (OR = 1.38, 95% CI, 0.53, 3.62; *P*=0.51). A significant difference was found in cohort studies (OR = 5.7, 95% CI, 1.78, 18.26; *P*=0.003) with low heterogeneity (*I*^2^ = 0%), in favor of the R group ([Figure 8](#fig8){ref-type="fig"}).

3.7. Complications {#sec3.7}
------------------

The overall complication rate was 8.2% (*n* = 38) in the remnant-preserving ACLR group (*n* = 466) and 7.1% (*n* = 38) in the standard ACLR group (*n* = 536). Complications that have been reported include range-of-motion (ROM) deficit, cyclops lesion, and knee instability. Of these complications, 84% (*n* = 64) were related to a ROM deficit (50%, *n* = 32) or cyclops lesion (50%, *n* = 32). There was no significant difference in RCT studies between the two groups with respect to complications (OR = 0.91, 95% CI, 0.39, 2.12; *P*=0.83). And no significant difference was observed when combined all studies (OR = 1.24 95% CI, 0.76, 2.02; *P*=0.39) ([Figure 9](#fig9){ref-type="fig"}).

4. Discussion {#sec4}
=============

The principal findings of this systematic review were as follows: (1) an superior outcome of postoperative knee anterior stability and Lysholm score in patients undergoing remnant-preserving ACLR compared with those undergoing standard ACLR; (2) a similar healing status of grafts during second-look arthroscopy in the remnant-preserving ACLR group than in the standard ACLR group; and (3) no significant difference in the overall complication rate between groups. The available evidence at present does not support the notion that remnant-preserving ACLR is significantly superior to standard ACLR.

Four weeks after ACLR, the synovium with blood vessels from the subpatellar fat pad and synovial tissue begins to cover the graft, which leads to the revascularization and survival of the graft \[[@B37]\]. ACL remnants retain a well-vascularized synovial sheet, numerous fibroblasts and myofibroblasts, and mechanoreceptors \[[@B7]--[@B9]\]. Animal studies have found that ACL remnants can accelerate the process of synovial coverage and revascularization and enhance the biomechanical properties of grafts \[[@B8], [@B14]\]. However, a significant proportion of clinical studies have reported that there is no difference in graft healing between remnant-preserving ACLR and standard ACLR \[[@B16]\]. Second-look arthroscopy is a good tool to evaluate graft healing by observing synovial coverage, graft tension, and the presence of partial tears and impingement, according to Kondo and Yasuda \[[@B35]\] and Lee et al. \[[@B36]\]. Second-look arthroscopy was performed in 4 studies included in this review \[[@B16], [@B17], [@B22], [@B24]\], and meta-analysis reported similar graft status in the R group than in the C group. Kondo et al. \[[@B17]\] reported that arthroscopic evaluations in remnant-preserving ACLR were significantly better than those in standard ACLR, which significantly affected postoperative knee stability. Lu et al. \[[@B22]\] reported a better arthroscopic evaluation score, faster ROM recovery, and higher subjective outcome scores in the remnant-preserving ACLR group. Nakayama et al. \[[@B16]\] found better arthroscopic evaluations but an increased incidence of postoperative extension loss in the remnant-preserving ACLR group. Hong et al. \[[@B24]\] reported no differences in arthroscopic evaluations and clinical outcomes between groups. Among the three studies \[[@B16], [@B17], [@B22]\] that reported a significantly better graft status in the R group, only Lu et al. \[[@B22]\] found better subjective knee function scores in the R group. The benefits of remnant-preserving ACLR may be potential and long-term accumulation while improving knee stability and reducing postoperative meniscus damage and osteoarthritic changes \[[@B17]\]. Perhaps with longer follow-up, some differences emerge which could be found in rerupture rates, subjective results, and posttraumatic arthritis. Therefore, more randomized controlled and long-term follow-up studies are needed to confirm these hypotheses.

This meta-analysis showed a superior outcome of postoperative knee anterior stability and Lysholm score in the remnant-preserving ACLR group compared with the standard ACLR group. However, there were no significant differences between the two groups in IKDC grade, IKDC scores, Lachman test, and pivot-shift test. We believe the biomechanical stability of the knee joint should be the primary purpose of performing a successful ACLR. Kondo et al. \[[@B17]\] reported that the remnant-preserving technique could significantly improve postoperative knee stability by increasing the initial graft coverage. Kondo et al. believe that remnant preservation may enhance the biomechanical properties of the graft, which may affect the long-term clinical results concerning postoperative meniscus damage and/or osteoarthritic changes. Lu et al. \[[@B22]\] also reported a better arthroscopic evaluation score and knee anterior stability in the remnant-preserving ACLR group. However, Hong et al. \[[@B24]\] suggested the dominant postoperative stability was provided by the ACL graft itself, and the strength of the remnant may not be large enough to contribute a significant difference. In addition, the postoperative tension of the remnant was not adequately maintained, as shown in cases of abnormal synovial coverage. So conducting both second-look arthroscopy and KT arthrometer in RCT might help us to clarify the correlation. Many studies have reported that mechanoreceptors in the ACL remnant can promote reinnervation and restoration of proprioception \[[@B10]--[@B13], [@B18]\]. However, few human studies \[[@B12], [@B24], [@B38], [@B39]\] have evaluated the effect of remnant preservation on the recovery of proprioception function, and these studies have shown inconsistent results. Only one study \[[@B24]\] included in this review evaluated proprioception with the passive angle reproduction (RPP) test designed by Barrett \[[@B40]\], and no significant difference was found between groups. Adachi et al. \[[@B38]\] previously reported a better proprioception function with the RPP test in the remnant-preserving ACLR group. Although RPP was used to evaluate proprioception after ACL reconstruction, its sensitivity and specificity still need to be improved. In addition, the knee proprioception system is complex and consists of mechanoreceptors located in the ligament, joint capsule, tendons, and muscles \[[@B41], [@B42]\]. Distinguishing the effect of remnant preservation on the restoration of proprioception is difficult. Therefore, more sensitive and specific equipment or systems need to be developed to assess the proprioceptive function of the knee.

Surgical timing is one of the key factors for graft healing. Several studies \[[@B9], [@B13], [@B43], [@B44]\] have reported a decreased number of mechanoreceptors in an ACL stump with the time from injury to surgery. In addition, several histological studies \[[@B45]--[@B48]\] have reported that the gene expression patterns of the ACL stump change from healing to fibering over time. Inokuchi et al. \[[@B49]\] suggest that ACL remnant preservation can promote and enhance tendon-bone healing in the early phase after injury. Ahn et al. \[[@B6]\] reported better graft synovial coverage and incorporation outcomes in the R group, with a shorter duration between injury and surgery. However, a meta-analysis \[[@B50]\] has suggested that the interval between injury and surgery does not affect clinical outcomes. At present, the optimal timing for remnant-preserving ACLR in the clinical setting is still not clear. The optimal graft choice of remnant-preserving ACLR remains controversial. The autograft has been the mainstay in standard ACLR for a lower donor site failure rate and good clinical outcomes \[[@B51]--[@B54]\]. However, few articles have compared the clinical outcomes of different graft types in remnant-preserving ACLR. In this review, most included articles \[[@B15]--[@B18], [@B20]--[@B23]\] reported good clinical outcomes using autografts in the remnant-preserving ACLR group. Hong et al. \[[@B24]\] chose allografts and reported similar outcomes of stability, functional scores, revascularization, and proprioceptive between groups. Notably, synthetic grafts without self-tissue sacrifice are also a good choice. Chen et al. \[[@B18]\] reported that clinical scores were statistically significantly higher at 6 months postoperatively with synthetics in the remnant preservation group than in the autograft group. At a mean of 10 years postoperatively, synthetics and hamstring autografts demonstrated similarly satisfactory outcomes. The relationship between the graft type and clinical outcomes after remnant-preserving ACLR should be further studied.

The remnant amount is another important factor. Lee et al. \[[@B12]\] reported that increasing the remnant amount can promote the restoration of proprioceptive function. Muneta et al. \[[@B55]\] compared the clinical outcomes of three groups (classified according to the remnant volume: ≤30, 35--55, and ≥60%) and found that the remnant volume was weakly correlated with the postoperative outcome. On the other hand, Nakayama et al. \[[@B16]\] indicated that a large remnant may increase the incidence of cyclops lesions and extension loss. The studies included in this systematic review rarely involve the remnant amount. Tibial tunnel widening is a common problem after ACL reconstruction \[[@B56]--[@B58]\]. Tibial tunnel widening could induce poor healing of graft because of infiltration of synovial fluid into the space between bone and graft. Previous studies \[[@B59], [@B60]\] have reported that remnants of ACL can cover the entry of the tibial tunnel and decrease the infiltration of synovial fluid. Three studies \[[@B15], [@B21], [@B23]\] included in this review measured tibial tunnel widening. Zhang et al. \[[@B21]\] and Demirag et al. \[[@B23]\] found few outcomes of tibial tunnel widening in the R group. The 2 studies measured tibial tunnel widening by radiography, which is not as accurate as computed tomography or MRI. In addition, these studies failed to find a correlation between tibial tunnel widening and knee joint stability at the final follow-up.

The main complications of the remnant-preserving technique were cyclops lesion and extension loss. This meta-analysis showed that there was no significant difference in the overall complication rate between groups. Nakayama et al. \[[@B16]\] reported increased extension deficits for knees with double-bundle remnant-preserving ACLR. The semitendinosus tendon that is folded in four for double-bundle ACLR needs a large volume, and the full volume of the preserved remnant with the suturing/tensioning technique described by Ahn et al. \[[@B32]\] takes up additional space. However, Kondo et al. \[[@B17]\] observed rare cyclops lesions in remnant-preserving ACLR with double-bundle ACLR that was similar to standard ACLR. Different remnant preservation techniques are also an influencing factor of the incidence of cyclops lesions. Selective-bundle augmentation is a different technique than standard ACLR with remnant preservation, which reconstructs a single-bundle (anteromedial bundle or posterolateral bundle) with the other bundle remnant preserved. Selective-bundle augmentation may have a smaller incidence of cyclops lesions because there are no excess remnant fibers. Kondo et al. \[[@B17]\] used the sparing technique in remnant-preserving ACLR, which reduces the volume of the remnant during the drilling and passage of the hamstring graft. This suggests that the sparing technique may have potential advantages over the tensioning technique in reducing the rate of cyclops lesions and extension deficits. However, partial or complete resection of preserved remnants can be considered for knees with narrow intercondylar fossa and large remnants \[[@B16]\].

5. Limitations {#sec5}
==============

This review has several limitations. First, to include high-quality studies, the number of included studies and patients was relatively small. Second, some prospective cohort studies included in this review and meta-analysis have selection bias, including heterogeneity in patient populations, surgical techniques, and measures of clinical outcomes, which leads to higher heterogeneity when simultaneously combining randomized controlled trials and cohort studies in subgroup meta-analysis. Third, the median follow-up duration in the studies was approximately two years, and longer follow-up is needed to evaluate the difference between the two techniques. Fourth, single-bundle augmentation is a different technique than standard ACLR with remnant preservation. However, subgroup analysis of surgical technique comparison was not performed in this review because of the small number of studies and the high heterogeneity. More research is needed in the future to compare these technologies.

6. Conclusion {#sec6}
=============

This systematic review showed that remnant-preserving ACLR promoted similar synovial coverage and revascularization of grafts to standard ACLR. Equivalent or superior outcomes of postoperative knee stability and clinical scores were observed in patients undergoing remnant-preserving ACLR compared with those undergoing standard ACLR. There was no significant difference in the rate of total complications between groups. Three different remnant-preserving techniques included in this review have respective advantages, and more research is needed in the future to compare these technologies. The currently available evidence is not sufficiently strong to support the superiority of remnant-preserving ACLR.
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###### 

Distributions of factors related to final results within studies.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                        Time from injury to surgery (mo)   Pattern of ACL rupture         Amount of remnant                                                   Type of graft    Procedure
  ---------------------------- ---------------------------------- ------------------------------ ------------------------------------------------------------------- ---------------- -----------------------------------------------------
  Pujol et al \[[@B25]\]       Group R: 4.5\                      Group R: partial\              Length: bridging femur and tibia in group R\                        Group R: auto\   Group R: selective-bundle augmentation\
                               Group C: 5                         Group C: partial               No remnant left in group C                                          Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Zhang et al. \[[@B21]\]      Group R: 12.7\                     Group R: complete\             Diameter: intact tibial remnant observed in both groups             Group R: auto\   Group R: standard ACLR + tibial remnant sparing\
                               Group C: 10.4                      Group C: complete                                                                                  Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Demirag et al. \[[@B23]\]    Group R: 2.3\                      Group R: partial\              Length: bridging femur and tibia in both groups\                    Group R: auto\   Group R: selective-bundle augmentation\
                               Group C: 8.0                       Group C: partial               Diameter: \>50% of native ACL in both groups                        Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Gohil et al. \[[@B19]\]      Group R: 1.9\                      NA                             NA                                                                  Group R: auto\   Group R: standard ACLR + tibial remnant sparing\
                               Group C: 2.4                                                                                                                          Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Lu et al. \[[@B22]\]         Group R: 0.8\                      Group R: complete\             Length: bridging femur and tibia in group R\                        Group R: auto\   Group R: standard ACLR + tibial remnant tensioning\
                               Group C: 0.8                       Group C: complete              No remnant left in group C                                          Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Hong et al. \[[@B24]\]       Group R: 10.3\                     Group R: complete\             Length: able to be pulled into femoral tunnel and in both groups\   Group R: allo\   Group R: standard ACLR + tibial remnant tensioning\
                               Group C: 9.4                       Group C: complete              Diameter: \>50% of native ACL in both groups                        Group C: allo    Group C: standard ACLR

                                                                                                                                                                                      

  Naraoka et al. \[[@B15]\]    NA                                 NA                             Length: \>25% of native ACL in group R\                             Group R: auto\   Group R: standard ACLR + tibial remnant tensioning\
                                                                                                 \<25% of native ACL in group C                                      Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Nakayama et al. \[[@B16]\]   Group R: 12\                       Group R: complete\             Diameter: ≥50% of native ACL in group R\                            Group R: auto\   Group R: standard ACLR + tibial remnant tensioning\
                               Group C: 12                        Group C: complete              No remnant left in group C                                          Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Kondo et al. \[[@B17]\]      Group R: 7\                        Group R: complete\             Length: bridging femur and tibia in group R\                        Group R: auto\   Group R: standard ACLR + tibial remnant tensioning\
                               Group C: 12                        Group C: complete              No remnant left in group C                                          Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Chen et al. \[[@B18]\]       Group R: 16.5\                     Group R: complete\             NA                                                                  Group R: LARS\   Group R: standard ACLR + tibial remnant sparing\
                               Group C: 18                        Group C: complete                                                                                  Group C: auto    Group C: standard ACLR

                                                                                                                                                                                      

  Rushton et al. \[[@B20]\]    \<3 mo: R 21, C 16\                Group R: complete + partial\   NA                                                                  Group R: auto\   Group R: standard ACLR + tibial remnant sparing\
                               \<3 mo: R 24, C 29                 Group C: complete + partial                                                                        Group C: auto    Group C: standard ACLR
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Allo, allograft; auto, autograft; R, remnant; C, control; NA, not available; mo, month; LARS, Ligament Augmentation Reinforcement System.

###### 

Distributions of factors related to final results within studies.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study                        Number of patients   Follow-up (mo)    Outcome measure                                              Results                                                                                                   Complications                                                  Conclusion
  ---------------------------- -------------------- ----------------- ------------------------------------------------------------ --------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------
  Pujol et al \[[@B25]\].      Group R: 29\         Group R: 12\      IKDC, Lysholm, KOOS, Rolimeter® knee tester                  IKDC, Lysholm, and KOOS improved in both groups\                                                          Cyclops lesions: 1 in group R                                  No difference in functional scores between groups\
                               Group C: 25          Group C: 12                                                                    Anterior laxity on Rolimeter®: 1.24 mm in group R vs. 1.87 mm in group C                                                                                                 Better short-term control of anterior laxity in group R than in group C

                                                                                                                                                                                                                                                                                                            

  Zhang et al. \[[@B21]\]      Group R: 27\         Group R: 24.4\    Lysholm, KT-1000 knee arthrometer\                           Lysholm and KT-1000 improved in both groups\                                                              NA                                                             No difference in functional score and joint stability between groups\
                               Group C: 24          Group C: 25.2     Radiographs: tibial tunnel widening                          Tibial tunnel widening: 12.9 ± 1.0 mm in group R vs. 13.9 ± 1.3 mm in group C                                                                                            Better tibial tunnel widening outcome in group R

                                                                                                                                                                                                                                                                                                            

  Demirag et al. \[[@B23]\]    Group R: 20\         Group R: 24.3\    IKDC and Lysholm\                                            IKDC and Lysholm improved in both groups\                                                                 Flexion loss: 7 in each group\                                 No differences in functional scores between groups\
                               Group C: 20          Group C: 24.3     Radiographs: tibial tunnel widening                          Tibial tunnel widening: 7.7 ± 0.5 mm in group R vs. 7.9 ± 0.5 mm in group C                               Cyclops lesions: 1 in group R                                  Better tibial tunnel widening outcome in group R

                                                                                                                                                                                                                                                                                                            

  Gohil et al. \[[@B19]\]      Group R: 24\         Group R: 12\      IKDC, KT-1000 knee arthrometer\                              IKDC and KT-1000 improved in both groups\                                                                 Extension loss: 2 in each group                                Earlier revascularization in group R than in group C
                               Group C: 25          Group C: 12       One-legged hop test\                                         MRI: significant reduction in midsubstance signal in group R at 2 and 6 mo postoperatively                                                                               
                                                                      MRI                                                                                                                                                                                                                                   

                                                                                                                                                                                                                                                                                                            

  Lu et al. \[[@B22]\]         Group R: 36\         Group R: 34.7\    IKDC, Lysholm, Tegner, KT-2000 knee arthrometer\             Better outcomes of IKDC, Lysholm, and KT-2000 in group R than in group C\                                 Knee instability: 2 in group C                                 Faster ROM recovery, higher subjective outcome scores, and better second-look arthroscopy in group R than in group C
                               Group C: 36          Group C: 39.6     Second-look arthroscopy                                      Evaluation of graft quality on arthroscopy: 4.6 ± 1.6 scores in group R vs. 3.9 ± 2.0 scores in group C                                                                  

                                                                                                                                                                                                                                                                                                            

  Hong et al. \[[@B24]\]       Group R: 39\         Group R: 25.8\    IKDC, Lysholm, KT-1000 knee arthrometer\                     IKDC, Lysholm, and KT-1000 improved in both groups\                                                       Cyclops lesions: 3 in each group                               No differences in stability, functional scores, revascularization, and proprioceptive outcomes between groups
                               Group C: 41          Group C: 25.5     Second-look arthroscopy\                                     Second-look arthroscopy: \>50% graft synovial coverage in 20/28 in group R vs. 19/27 in group C\                                                                         
                                                                      Proprioceptive testing: RPP test                             RPP test: 3.6° ± 1.8° in group R vs. 3.9° ± 2.2° in group C                                                                                                              

                                                                                                                                                                                                                                                                                                            

  Naraoka et al. \[[@B15]\]    Group R: 77\         Group R: 24\      Lysholm, KT-1000 knee arthrometer\                           Lysholm and KT-1000 improved in both groups\                                                              Rerupture: 5 in group R and 6 in group C                       No difference in stability and graft incorporation between groups
                               Group C: 74          Group C: 24       Magnetic resonance imaging: MRI\                             MRI: similar result of maturation scores and tibial tunnel integration scores between groups                                                                             

                                                                                                                                                                                                                                                                                                            

  Nakayama et al. \[[@B16]\]   Group R: 50\         Group R: 12\      Heel height difference, Lysholm, KT-1000 knee arthrometer\   Lysholm and KT-1000 improved in both groups\                                                              Extension loss: 6 in group R and 3 in group C                  Better tissue healing but higher incidence of extension loss in group R than in group C
                               Group C: 75          Group C: 12       Second-look arthroscopy                                      Second-look arthroscopy: 92% good status of grafts in group R vs. 59% good in group C                                                                                    

                                                                                                                                                                                                                                                                                                            

  Kondo et al. \[[@B17]\]      Group R: 81\         Group R: 24\      IKDC, Lysholm, KT-2000 knee arthrometer\                     No difference in IKDC and 3D-CT between groups\                                                           Cyclops lesions: 9 in group R and 8 in group C (no symptoms)   Postoperative knee stability significantly improved in group R
                               Group C: 98          Group C: 24       3-Dimensional computed tomography: 3D-CT\                    Anterior laxity on KT-2000 : 43/81 \< 1 mm in group R vs. 33/98 \< 1 mm in group C\                                                                                      
                                                                      Second-look arthroscopy                                      Second-look arthroscopy: excellent status of grafts in 59/81 in group R vs. 37/98 in group C                                                                             

                                                                                                                                                                                                                                                                                                            

  Chen et al. \[[@B18]\]       Group R: 38\         Group R: 120.8\   IKDC, Lysholm, KOOS, Tegner\                                 Better scores of IKDC, Lysholm, KOOS, and Tegner in group R than in group C at 6 mo postoperatively       Screw-related problem: 3 in R and 2 in C\                      Earlier symptom relief and restoration of function in group R than in group C
                               Group C: 73          Group C: 122.9    Radiography                                                                                                                                                            Donor site morbidity: 3 in C\                                  
                                                                                                                                                                                                                                             Superficial infection: 1 in C\                                 
                                                                                                                                                                                                                                             Synovitis: 1 in R                                              

                                                                                                                                                                                                                                                                                                            

  Rushton et al. \[[@B20]\]    Group R: 45\         Group R: 12\      IKDC, KT-2000 knee arthrometer\                              IKDC improved in both groups\                                                                             Cyclops lesions:1 in group R                                   Better knee stability and quality of life in group R than in group C
                               Group C: 45          Group C: 12       ACL-QOL (ACL-quality of life)                                ACL-QOL: improved scores of 54.7 in group R vs. 46.1 in group C\                                                                                                         
                                                                                                                                   Side-to-side difference on KT-2000 : 2.1 ± 1.3 mm in group R vs. 3.0 ± 1.7 mm in group C                                                                                 
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

R, remnant; C, control; NA, not available; IKDC, International Knee Documentation Committee; KOOS, Knee Injury and Osteoarthritis Outcome Score.

###### 

Study features.

  Study                        Publication year   Country     Type of study                 Level of evidence   CMS score
  ---------------------------- ------------------ ----------- ----------------------------- ------------------- -----------
  Pujol et al. \[[@B25]\]      2012               France      Randomized controlled trial   I                   79
  Zhang et al. \[[@B21]\]      2012               China       Randomized controlled trial   I                   89
  Demirag et al. \[[@B23]\]    2012               Turkey      Randomized controlled trial   I                   87
  Gohil et al. \[[@B19]\]      2007               Australia   Randomized controlled trial   I                   91
  Lu et al. \[[@B22]\]         2015               China       Randomized controlled trial   II                  92
  Hong et al. \[[@B24]\]       2012               China       Randomized controlled trial   II                  92
  Naraoka et al. \[[@B15]\]    2017               Japan       Prospective cohort study      II                  87
  Nakayama et al. \[[@B16]\]   2017               Japan       Prospective cohort study      II                  84
  Kondo et al. \[[@B17]\]      2015               Japan       Prospective cohort study      II                  77
  Chen et al. \[[@B18]\]       2012               China       Prospective cohort study      II                  87
  Rushton et al. \[[@B20]\]    2012               Canada      Prospective cohort study      II                  79

CMS score, the modified Coleman methodology score.

###### 

Detailed CMS for included studies.

  Study                        Publication year   Study size   Mean follow-up   Number of procedures   Type of study   Diagnostic certainty   Surgery description   Rehabilitation description   Outcome criteria   Procedure for outcome   Selection process   Total score
  ---------------------------- ------------------ ------------ ---------------- ---------------------- --------------- ---------------------- --------------------- ---------------------------- ------------------ ----------------------- ------------------- -------------
  Pujol et al. \[[@B25]\].     2012               7            2                10                     15              5                      3                     0                            10                 12                      15                  79
  Zhang et al. \[[@B21]\]      2012               7            5                10                     15              5                      5                     10                           10                 12                      10                  89
  Demirag et al. \[[@B23]\]    2012               4            5                10                     15              5                      5                     0                            10                 12                      15                  87
  Gohil et al. \[[@B19]\]      2007               7            2                10                     15              5                      5                     10                           10                 12                      15                  91
  Lu et al. \[[@B22]\]         2015               10           5                10                     10              5                      5                     10                           10                 12                      15                  92
  Hong et al. \[[@B24]\]       2012               10           5                10                     15              5                      5                     10                           10                 12                      10                  92
  Naraoka et al. \[[@B15]\]    2017               10           5                10                     10              5                      5                     10                           10                 12                      10                  87
  Nakayama et al. \[[@B16]\]   2017               10           2                10                     10              5                      5                     10                           10                 12                      10                  84
  Kondo et al. \[[@B17]\]      2015               10           5                10                     10              5                      5                     0                            10                 12                      10                  77
  Chen et al. \[[@B18]\]       2012               10           5                10                     10              5                      5                     10                           10                 12                      10                  87
  Rushton et al. \[[@B20]\]    2012               10           2                10                     10              5                      5                     0                            10                 12                      15                  79

###### 

Descriptions of 3 different remnant preservation techniques.

  Tibial remnant tensioning \[[@B32]\]                                                                      Selective-bundle augmentation \[[@B33]\]                                                                                                                                                                Tibial remnant sparing \[[@B34]\]
  --------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------
  Several sutures of the remnant ACL were placed near the proximal end.                                     When the ACL remnant was attached to the anteroinferior portion of the anatomic femoral origin and the posterolateral (PL) bundle was well preserved, the anteromedial (AM) bundle was reconstructed.   The tibial tunnel position was within the boundaries of the ACL tibial remnant.
                                                                                                                                                                                                                                                                                                                    
  Medial traction of these sutures provided a wide view during the reconstruction.                          When the ACL remnant was attached to the high-noon position with a well-preserved AM bundle, the PL bundle was reconstructed.                                                                           The ACL graft was allowed to pass through the tibial tunnel within the tibial remnant.
                                                                                                                                                                                                                                                                                                                    
  Fixation was performed with a slightly smaller tension with the tibial remnant from the femoral tunnel.                                                                                                                                                                                                            
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